Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 MAR 24 ... represented more than 800 consumers who suffered heart attacks or strokes after taking Vioxx – Merck’s blockbuster drug that was recalled in 2004.
“Formalizing the ...
2009 MAR 24 ... represented more than 800 consumers who suffered heart attacks or strokes after taking Vioxx – Merck’s blockbuster drug that was recalled in 2004.
“By formalizing ...
2009 MAR 30 ... surrounding the cardiovascular complications associated with the long term use of Vioxx and other "COX-2" analgesics. This is remarkable since simple analgesics such as ...
2009 NOV 16 ... cash flow of $2.13 billion at Merck, driven lower by $1.39 billion of payments into the Vioxx settlement and a $660 million tax settlement during 2009, was not fully offset by a ...
2009 AUG 17 ... Merck and Company, Inc. (NYSE:MRK) on behalf of health benefit providers who purchased Vioxx in a suit claiming the pharmaceutical giant launched misleading marketing campaigns for ...
2009 APR 6 ... anti-inflammatory drugs (NSAIDs) like ibuprofen or with selective COX-2 inhibitors like Vioxx or Celebrex – reduces the number and size of colon polyps in mice and in patients with ...
2009 APR 6 ... grand jury investigation. The investigation relates to activities in connection with VIOXX, a medicine that Merck voluntarily withdrew from the market in 2004. The company has ...
2009 NOV 23 ... Eastern District of New York, as a member of the State-Federal Liaison Committee for the Vioxx Multidistrict Litigation in the Eastern District of Louisiana, and as Co-Lead Counsel ...
Subject: Burg Simpson Eldredge Hersh & Jardine, P.C.
2009 JUL 14 ... Court of the Eastern District of New York and to the State Liaison Committee in the Vioxx MDL Litigation by the Honorable Eldon Fallon, Eastern District of Louisiana. Mr. Burg is ...
Subject: Burg Simpson Eldredge Hersh & Jardine, P.C.
2009 JUL 21 ... a settlement in the consolidated class action against the manufacturer of the drug Vioxx. Parker Waichman Alonso LLP was the first law firm in the country to file a class action ...
2009 MAY 25 ... polyps, a precursor to colorectal cancer. But two blockbuster COX-2 inhibitors, Vioxx (rofecoxib) and Bextra (valdecoxib), were pulled off the market after reports that they ...
Subject: New York- Presbyterian Hospital/Weill Cornell Medical Center/Weill Cornell Medical College
2009 MAY 18 ... of drug safety have gone up and down. As stories break about drug problems – and Vioxx® comes to mind—those numbers change. We seem to have recovered from the low figures of ...
2009 NOV 2 ... set to study the role of learning in the diffusion of three Cox-2 Inhibitors-Celebrex, Vioxx and Bextra-before the Vioxx withdrawal. Our study has ...
2009 OCT 19 ... suffered cardiovascular injuries linked to the company's anti-inflammatory medication Vioxx. NLJ editors noted that without losing step, Seeger Weiss kept pace over the past 12 ...
2009 JUN 29 ... comparative effectiveness research: Generate the data more rapidly. The pain reliever Vioxx is the best-known example of a drug originally aimed at a narrow patient population that ...
2009 NOV 23 ... According to recent research from the United States, "In the 5 years since the Vioxx debacle, efforts have been made to enhance drug safety." "These include ...
2009 SEP 29 ... against Merck & Co. Inc. in litigation related to the controversial pain medication Vioxx. Two of his prior court victories have been recognized by The National Law Journal as ...
2009 MAR 23 ... Most recently representing more than 800 plaintiffs as co-liaison counsel in the N.J Vioxx litigation, and serving as co-chair of the American Association for Justice preemption ...
2009 JUN 1 ... deadly effects still do not emerge until they are on the market. In the case of Vioxx, millions of people had already used the pain-killer and arthritis medication before ...
Subject: University of North Carolina School of Medicine
2009 OCT 12 ... a diabetic who suffered a heart attack due to his use of Merck's prescription drug Vioxx. The Order fully affirmed an earlier court's compensatory award of $3 million for Mr. ...
